- Country: Russia
- Summary: Supply of Reagents for the Automatic Closed-Type Immunochemiluminescent Analyzer Maglumi 4000 Plus, Manufactured by Shenzhen New Industry Biomedical Engineering...
- RUT Ref No: 104962222
- Deadline: 31 Jul 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 379800.00
- Notice Type: Tender
- Document Ref. No.: 0369200000524000369
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of reagents for the closed-type automatic immunochemiluminescent analyzer MAGLUMI 4000 Plus, manufactured by Shenzhen New Industry Biomedical Engineering Co., Ltd., China
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Reagents for the Automatic Closed-Type Immunochemiluminescent Analyzer Maglumi 4000 Plus, Manufactured by Shenzhen New Industry Biomedical Engineering... - Russia Tender
The STATE BUDGET HEALTH INSTITUTION "CHELYABINSK REGIONAL CLINICAL HOSPITAL, a Government sector organization in Russia, has announced a new tender for Supply of Reagents for the Automatic Closed-Type Immunochemiluminescent Analyzer Maglumi 4000 Plus, Manufactured by Shenzhen New Industry Biomedical Engineering.... This tender is published on RussiaTenders under RUT Ref No: 104962222 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-07-31.
The estimated tender value is RUB 379800.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
